Pfizer Covid Vaccines
Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt

Report 93: Pfizer’s ‘Post-Marketing Surveillance Report’ Reveals That Pfizer Manipulated Data and Wrongly Tabulated Adverse Events, Which Concealed Them.

We evaluated Pfizer’s 38-page “5.3.6 Cumulative Analysis of Post-Authorization Adverse Events Reports of PF-07302048 (BNT162b2) received through 28-Feb-2021,” commonly known as “5.3.6,” starting in September of 2022. Patterns emerged across the System Organ Classes (SOCs). These patterns included Pfizer’s apparent concealment of various cases of adverse events, as well as […]

Pfizer COVID vaccine
Lora Hammill BSMT, ASCP; David Shaw; Chris Flowers M.D.; Loree Britt; Joseph Gehrett M.D.; Barbara Gehrett M.D.; Michelle Cibelli RN, BSN; Margaret Turoski, RPh; Cassie B. Papillon; and Tony Damian

Report 87: In Early 2021, Pfizer Documented Significant Harms and Deaths Following Vaccination with Its mRNA COVID Vaccine. The FDA Did Not Inform the Public.

INTRODUCTION “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021,” Pfizer’s post-marketing report, a required U.S. Food and Drug Administration (FDA) compliance document, is one of the ways in which the FDA assessed patients’ risks associated with Pfizer’s COVID-19 vaccine, BNT162b2. The data within the […]

musculoskeltal
Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt

Report 71: Musculoskeletal Adverse Events of Special Interest Afflicted 8.5% of Patients in Pfizer’s Post-Marketing Data Set, Including Four Children and One Infant. Women Affected at a Ratio of Almost 4:1 Over Men.

The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a review of musculoskeletal adverse events of special interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 […]